JP2005517677A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517677A5
JP2005517677A5 JP2003556413A JP2003556413A JP2005517677A5 JP 2005517677 A5 JP2005517677 A5 JP 2005517677A5 JP 2003556413 A JP2003556413 A JP 2003556413A JP 2003556413 A JP2003556413 A JP 2003556413A JP 2005517677 A5 JP2005517677 A5 JP 2005517677A5
Authority
JP
Japan
Prior art keywords
aryl
lower alkyl
lower alkoxy
cycloalkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003556413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517677A (ja
JP4188839B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/014771 external-priority patent/WO2003055883A1/en
Publication of JP2005517677A publication Critical patent/JP2005517677A/ja
Publication of JP2005517677A5 publication Critical patent/JP2005517677A5/ja
Application granted granted Critical
Publication of JP4188839B2 publication Critical patent/JP4188839B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003556413A 2001-12-27 2002-12-27 ホスファターゼインヒビーターとしてのピリミドトリアジン Expired - Fee Related JP4188839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US39911002P 2002-07-26 2002-07-26
PCT/EP2002/014771 WO2003055883A1 (en) 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors

Publications (3)

Publication Number Publication Date
JP2005517677A JP2005517677A (ja) 2005-06-16
JP2005517677A5 true JP2005517677A5 (https=) 2005-12-22
JP4188839B2 JP4188839B2 (ja) 2008-12-03

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003556413A Expired - Fee Related JP4188839B2 (ja) 2001-12-27 2002-12-27 ホスファターゼインヒビーターとしてのピリミドトリアジン

Country Status (19)

Country Link
US (1) US6642381B2 (https=)
EP (1) EP1467996B1 (https=)
JP (1) JP4188839B2 (https=)
KR (1) KR100601769B1 (https=)
CN (1) CN100402530C (https=)
AT (1) ATE311388T1 (https=)
AU (1) AU2002367190B2 (https=)
BR (1) BR0215395A (https=)
CA (1) CA2471265C (https=)
DE (1) DE60207759T2 (https=)
ES (1) ES2252554T3 (https=)
JO (1) JO2242B1 (https=)
MX (1) MXPA04006266A (https=)
PA (1) PA8562901A1 (https=)
PE (1) PE20030896A1 (https=)
PL (1) PL371180A1 (https=)
TW (1) TW200306313A (https=)
UY (1) UY27606A1 (https=)
WO (1) WO2003055883A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2463615C (en) * 2001-10-30 2011-07-26 Applied Research Systems Ars Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
KR20050075028A (ko) 2002-11-18 2005-07-19 에프. 호프만-라 로슈 아게 다이아지노피리미딘
WO2004071448A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
CA2514363A1 (en) * 2003-02-12 2004-08-26 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
CA2551909C (en) * 2004-02-12 2011-10-11 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
NZ569329A (en) 2006-01-30 2011-09-30 Transtech Pharma Inc Substituted imidazole derivatives and their use as PTPase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
US9889108B2 (en) 2013-03-15 2018-02-13 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194410B1 (en) * 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Similar Documents

Publication Publication Date Title
JP2005517677A5 (https=)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2004516314A5 (https=)
JP2005535586A5 (https=)
JP2005539088A5 (https=)
CA2471265A1 (en) Pyrimidotriazines as phosphatase inhibitors
RU2006133898A (ru) Производные бензимидазола и его применение
JP2006524222A5 (https=)
JP2008519840A5 (https=)
JP2007505877A5 (https=)
JP2006525944A5 (https=)
JP2005533835A5 (https=)
JP2005508967A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2001526218A5 (https=)
JP2007507494A5 (https=)
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
JP2005526024A5 (https=)
RU2005121908A (ru) Производные зн-хиназолин-4-она
RU2004111601A (ru) Пиперидиновые производные и их применение в качестве модуляторов активности р ецепторов хемокина (в частности ccr5)
JP2004525178A5 (https=)
JP2005517008A5 (https=)
JP2006510606A5 (https=)
JP2005519885A5 (https=)
JP2005532397A5 (https=)